Assembly Biosciences is advancing its herpes drug to Phase II trials after it showed 94% antiviral efficacy in a Phase Ib ...

Biopharmaceutical company Gilead Sciences (NASDAQ:GILD) beat Wall Street’s revenue expectations in Q2 CY2025, with sales up 1 ...

Gilead Sciences, Inc. (NASDAQ:GILD) is among the 11 Best GLP-1 and Weight Loss Stocks to Invest in. Gilead Sciences, Inc.

• Mount Gilead at Upper Sandusky, girls’ golf, 1:30 p.m. • Mount Gilead, Fredericktown and Harding at Cardington, boys’ golf, 4:30 p.m. • Northmor at Margaretta, girls’ golf, 5 p.m. • Highland at ...

A Menlo Park medical device startup is breathing new life into the fight against severe emphysema with a groundbreaking ...

A wave of factory closures is reshaping regional economies, displacing skilled laborers and weakening supply chains.

Gilead Sciences delivered a breakout performance Friday, surging 8.3% to $119.41 in its strongest single-day gain in nearly ...

By R.A. Mathews Christian music, in my humble opinion, is as good as it gets. I added Riley Clemmons’ song “Fighting for Me” ...

Arcus Biosciences nears key catalysts with late-stage assets & upcoming Phase 3 data. Discover potential upside & why it's ...

Even though oncology segment revenue inched up just 1 percent year over year, the firm lifted full-year expectations slightly ...

Analysts lift targets for Gilead as HIV sales surge and Yeztugo launch gains traction, supporting a stronger full-year ...